Laurion Capital Management’s CRISPR Therapeutics CRSP Stock Holding History

Laurion Capital Management’s Portfolio CRSP Stock Details CRSP Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell
2019 Q4	$6.09M	Buy
2018 Q4	–	Sell
2018 Q3	$7.66M	Buy
2017 Q4	–	Sell
2017 Q3	$1.21M	Buy
2017 Q1	–	Sell
2016 Q4	$527K	Buy